Ketamine-Assisted Psychotherapy: What Therapists Need to Know About This Emerging Treatment Approach

Ketamine is no longer a treatment that therapists can assume will stay outside the therapy room.

Clients are hearing about ketamine therapy from psychiatrists, treatment centers, social media, and other mental health professionals. Some are wondering whether ketamine could help them. Others may already be receiving treatment and want support making sense of the experience.

That leaves many clinicians in an unfamiliar position: not prescribing ketamine or providing ketamine-assisted psychotherapy (KAP), but still needing enough knowledge to respond thoughtfully.

As ketamine becomes more visible in mental health care, a basic understanding of KAP, ketamine safety, client preparation, integration, and collaborative care is becoming increasingly relevant for therapists, social workers, counselors, and other behavioral health clinicians.

Why Therapists Need to Understand Ketamine-Assisted Psychotherapy Now?

Clients are asking before many therapists have had formal KAP training

A therapist does not need to offer psychedelic-assisted therapy for the subject to enter their practice.

A client may ask, “Do you think ketamine could help me?” Another may want to compare a ketamine infusion clinic with a psychotherapy-based model. Someone else may have had an emotionally intense or dissociative experience during treatment and bring that material into their regular therapy session.

These conversations can quickly touch on screening, risks, preparation, integration, and the roles of different providers.

Introductory ketamine therapy training for therapists can help clinicians understand what they can address, what requires collaboration, and what should be referred back to a medical provider.

The ketamine treatment landscape can be confusing

“Ketamine therapy” can refer to very different kinds of care.

Ketamine is FDA-approved as an anesthetic, but it is not FDA-approved for treating psychiatric disorders. Esketamine, a related medication, has specific FDA-approved psychiatric indications, while racemic ketamine is used off-label in some mental health settings.

Understanding the difference between ketamine treatment, esketamine treatment, and ketamine-assisted psychotherapy is an important starting point for informed clinical conversations.

Where Psychotherapy Fits Within Ketamine Treatment?

Ketamine-assisted psychotherapy differs from medication-only ketamine treatment because the therapeutic process extends beyond administration. For therapists, the focus is not on dosing, but on understanding how the treatment setting, route of administration, and level of medical support may shape the client’s psychological experience.

Route of Administration Shapes the Clinical Experience

Ketamine may be administered intravenously, intramuscularly, intranasally, orally, or sublingually. Each route can differ in onset, intensity, duration, and monitoring requirements, which may influence how a client prepares for and experiences treatment.

Preparation and Integration Give the Experience Therapeutic Context

Psychotherapy can help clients prepare for uncertainty, altered perception, and emotional material that may emerge. After treatment, integration offers space to explore the experience, connect it with ongoing therapeutic goals, and identify meaningful behavioral, emotional, or relational shifts without over-interpreting or imposing meaning on what occurred.

What Therapists Should Know Before Supporting a Client Using Ketamine

A foundational understanding of KAP gives therapists a framework for asking better questions. Several areas are especially useful:

  • Terminology and treatment models: Understand the difference between ketamine treatment, esketamine, ketamine infusions, and ketamine-assisted psychotherapy.
  • Scope of practice: Know which conversations belong within psychotherapy and which require a physician, psychiatric prescriber, or other qualified medical professional.
  • Screening and contraindications: Understand that ketamine requires medical assessment and that health history, medications, psychiatric presentation, substance use, and other factors may affect suitability and safety.
  • Preparation: Learn how therapists may help clients explore expectations, fears, intentions, and questions before treatment without stepping into medical advice.
  • Integration: Understand how post-ketamine psychotherapy can help clients process emotional material and relate insights to ongoing treatment.
  • Collaborative care: Recognize when communication among the therapist, prescriber, and other members of the treatment team may be important.

These gaps matter even for therapists who are not building a KAP practice. Without this foundation, clinicians may treat different forms of ketamine care as interchangeable, answer medical questions outside their scope, overlook preparation and integration, or interpret an experience too quickly.

The research also gives clinicians a reason to stay measured. A 2026 systematic review examining ketamine-assisted psychotherapies found a wide range of therapeutic approaches and psychiatric applications, but only 11 of the 72 included studies were randomized controlled trials. The authors noted that questions about optimal protocols and the additional or synergistic role of psychotherapy still require stronger controlled research.

That makes informed curiosity more useful than either enthusiasm or dismissal.

The Therapist’s Role Before, During, and After Ketamine Treatment

Before treatment: preparation without over-directing

Preparation for ketamine-assisted psychotherapy can include exploring what a client hopes for, what they fear, how they respond when they feel less in control, and what helps them feel grounded.

There are also limits to that preparation. Setting an intention is different from promising an outcome. Educating a client about possible experiences is different from suggesting what they should experience.

During treatment: support, boundaries, and setting

Not every therapist will be present during a ketamine session. For clinicians who do provide KAP, altered states can introduce distinct considerations around therapeutic presence, consent, boundaries, communication, and when to intervene.

This is also where introductory education and clinical competency should be distinguished.

Learning the fundamentals can help a therapist understand the KAP treatment process. Actually offering KAP requires deeper consideration of training, licensure, ethics, medical collaboration, supervision, and the treatment model being used.

After treatment: making integration clinically useful

Clients may return from ketamine treatment with insights, difficult emotions, symbolic material, fragmented memories, or uncertainty about what the experience meant.

Integration does not require treating every perception as profound. It can involve grounded questions: What stood out? What feels relevant now? Did anything shift in how the client understands an existing pattern? Is there something they want to explore differently?

For clients who already have a trusted therapist, that therapeutic relationship may become an important part of the ketamine integration process, even when treatment happens elsewhere.

JOIN OUR UPCOMING TRAINING

KAP Bootcamp for Psychotherapists

Take your understanding of Ketamine-Assisted Psychotherapy (KAP) from theory to practical clinical application. Join Dr. Sophia Brandstetter and Diane Nachamkin for the KAP Bootcamp for Psychotherapists, a live virtual training taking place on November 12–13, 2026.

Across 6 CE hours, this training will cover:

  • Client candidacy
  • Prescriber relationships
  • Informed consent
  • Preparation and medicine sessions
  • Integration and treatment planning
  • Legal and ethical considerations
  • Practical considerations for clinical practice

Live Virtual Training | November 12–13, 2026

REGISTER NOW

Picture of Sophia Brandstetter

Sophia Brandstetter

Dr. Sophia Brandstetter, LCSW, PsyD, specializes in complex and generational trauma. She is the founder of The Ko-Op, a Philadelphia-based center offering Ketamine-Assisted Psychotherapy. In addition to treating clients, she trains fellow clinicians in this modality. Her work integrates psychodynamic, mindfulness, and relational approaches with expanded states of consciousness for deep healing and transformation.